You are viewing the site in preview mode
Skip to main content
|
Parameters
|
HV
|
PP
|
MM
|
|---|
|
CD3+CD8+ (%)
|
+
|
+
|
+
|
|
CD107a+ (%)
|
+
|
+
|
+
|
|
IFN-γ+ (%)
|
+
|
+
|
+
|
|
Granzyme B+ (%)
|
Before
|
+
|
+
|
+
|
|
After
|
+
|
++
|
+
|
|
After-Before
|
+
|
++
|
+
|
|
Perforin+ (%)
|
Before
|
++
|
+++
|
+++
|
|
After
|
++
|
+++
|
++
|
|
After-Before
|
++
|
++
|
+
|
|
CD45RA- (%)
|
+
|
++
|
++
|
|
CD3+CD8+ (cell number)
|
++
|
+
|
+
|
- HV healthy volunteers, PP asbestos-exposed individuals with pleural plaque, MM asbestos-exposed patients with malignant mesothelioma, Before the percentage of granzyme B+ cells in fresh CD8+ lymphocytes, After the percentage of granzyme B+ cells in stimulated CD8+ lymphocytes, After-Before the percentage of granzyme B+ or perforin+ cells in fresh CD8+ lymphocytes was subtracted from the percentage of granzyme B+ or perforin+ cells in stimulated cells